RecruitingNCT01838148

Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia

BASEL VIII Trial - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia


Sponsor

University Hospital, Basel, Switzerland

Enrollment

4,000 participants

Start Date

May 1, 2004

Study Type

OBSERVATIONAL

Conditions

Summary

The primary aim is to perform the largest study worldwide to evaluate novel biochemical and electrocardiographic signatures alone as well as in combination with the standard 12-lead exercise ECG in the detection of exercise-induced myocardial ischemia (diagnostic endpoint). The secondary aim is to evaluate these innovative tools in the risk prediction for the occurrence of cardiovascular death and acute myocardial infarction during long-term follow-up.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients presenting with suspected exercise-induced myocardial ischemia referred for rest/ergometry myocardial perfusion SPECT

Exclusion Criteria4

  • Age < 18 years
  • Pregnancy
  • Unable or unwilling to give informed consent
  • Symptoms at rest or minor exertion

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01838148


Related Trials